Abacus Life, Inc. (ABL)
(Real Time Quote from BATS)
$10.98 USD
+0.20 (1.86%)
Updated Jul 24, 2024 01:20 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
ABL 10.98 +0.20(1.86%)
Will ABL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ABL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ABL
Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?
ABL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ABL
Western Alliance Posts Upbeat Earnings, Joins Abacus Life, SLB And Other Big Stocks Moving Higher On Friday
Morgan Stanley Keeps Their Hold Rating on Abbott Laboratories (ABT)
Maintained Buy Rating for Abbott Laboratories on Strong Financials and Growth Prospects
Abacus Life Provides Preliminary Second Quarter 2024 Results
Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA